CGS Share Price

Open 1.09 Change Price %
High 1.09 1 Day -0.02 -1.83
Low 1.06 1 Week 0.00 0.00
Close 1.07 1 Month -0.08 -6.96
Volume 50470 1 Year 0.42 64.62
52 Week High 1.39
52 Week Low 0.65
CGS Important Levels
Resistance 2 1.10
Resistance 1 1.09
Pivot 1.07
Support 1 1.05
Support 2 1.04
ASX Australia Most Active Stocks
DUE 3.02 1.00%
DUE 3.02 1.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
AGO 0.02 0.00%
AGO 0.02 0.00%
AGO 0.02 0.00%
NSL 0.02 0.00%
NSL 0.02 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
CVS 0.02 100.00%
CVS 0.02 100.00%
CVS 0.02 100.00%
CVS 0.02 100.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
BLY 0.03 50.00%
PMQ 0.03 50.00%
More..
ASX Australia Top Losers Stocks
DDD 0.00 -100.00%
DDD 0.00 -100.00%
DDD 0.00 -100.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
GDY 0.01 -50.00%
AZM 0.02 -33.33%
More..

Cogstate Ltd (ASX: CGS)

CGS Technical Analysis 3
As on 21st Jul 2017 CGS Share Price closed @ 1.07 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.03 & Buy for SHORT-TERM with Stoploss of 1.05 we also expect STOCK to react on Following IMPORTANT LEVELS.
CGS Target for July
1st Target up-side 1.22
2nd Target up-side 1.28
3rd Target up-side 1.34
1st Target down-side 1.06
2nd Target down-side 1
3rd Target down-side 0.94
CGS Other Details
Segment EQ
Market Capital 0.00
Sector Technology
Industry Healthcare Information Services
Offical website http://www.cogstate.com
CGS Address
CGS
255 Bourke Street
Level 2
Melbourne, VIC 3000
Australia
Phone: 61 3 9664 1300
CGS Latest News
Shares Running on Volume: CogState Ltd (CGS.AX)   Ozark Times   - 13th Jul 17
Why the CogState Limited share price fell 7% today   Motley Fool Australia   - 11th Jul 17
CogState Limited (ASX:CGS): Is it now really a good time to buy?   Simply Wall St   - 22nd Jun 17
Why the CogState Limited share price rocketed a massive 27% today   Motley Fool Australia   - 23rd May 17
Cogstate Selected as Preferred Provider to Lilly's Alzheimer's Disease Platform   Business Wire (press release)   - 17th May 17
Is CogState Limited's (ASX:CGS) stock available for good price when we account ...   Simply Wall St   - 11th Apr 17
Here's why the shares of CogState Limited rocketed 22% today   Motley Fool Australia   - 17th Oct 16
CogState Ltd hits $27M in revenues from cognitive tools   Proactive Investors Australia   - 20th Jul 16
Cogstate Limited: Presentation, CEO Sessions Sydney   Finance News Network   - 29th Jun 16
Cogstate Limited clinches US$4.9M in cognitive test contracts   Proactive Investors Australia   - 27th Apr 15
Interactive Technical Analysis Chart Cogstate Ltd ( CGS ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Cogstate Ltd
CGS Business Profile
CogState Limited, a multi-faceted cognitive assessment and training company, is engaged in the development and commercialization of rapid, computerized tests of cognition. It operates in three segments: Clinical Trials, Sport Market, and Primary Care Physician Market. The company offers computerized tests that are suited for relevant patient populations. It also provides DataPoint, an online data management software that enables real time central monitoring, cleaning, transfer, and analysis of clinical data; and scale management, rater training, and central monitoring services for paper and pencil neuropsychological tests, rating scales, questionnaires, and patient reported outcomes. In addition, it offers COGNIGRAM, a testing tool to assess cognition in patients; and CogState Research, a repeatable and sensitive computerized cognitive testing system designed for use in research studies. Further, the company is involved in the development of sport specific training products to assess, monitor, and improve the athletic brain. Its products and services are used by pharmaceutical, biotechnology, nutraceutical, and functional food companies to quantify the effect of disease and of drugs, devices, or other interventions on human subjects participating in clinical trials, as well as various markets, such as academic research, and concussion management for athletes. CogState Limited was founded in 1999 and is headquartered in Melbourne, Australia.